Acorda Therapeutics Price on May 12, 2023
ACORDelisted Stock | USD 16.20 0.40 2.41% |
If you're considering investing in Acorda Stock, it is important to understand the factors that can impact its price. As of today, the current price of Acorda Therapeutics stands at 16.20, as last reported on the 30th of November, with the highest price reaching 16.60 and the lowest price hitting 15.17 during the day. We have found thirty technical indicators for Acorda Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Acorda Therapeutics' Mean Deviation of 5.6, risk adjusted performance of 0.0834, and Downside Deviation of 5.94 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
Acorda Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Acorda |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
ACOR |
Based on monthly moving average Acorda Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Acorda Therapeutics by adding Acorda Therapeutics to a well-diversified portfolio.
Related Headline
Sunshine Biopharma Headline on 12th of May 2023
Financings for May 12, 2023 - BioWorld Online by news.google.com
Financings for May 12, 2023 BioWorld Online
Acorda Therapeutics Valuation on May 12, 2023
It is possible to determine the worth of Acorda Therapeutics on a given historical date. On May 12, 2023 Acorda was worth 0.84 at the beginning of the trading date compared to the closed value of 13.9. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Acorda Therapeutics stock. Still, in general, we apply an absolute valuation method to find Acorda Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Acorda Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Acorda Therapeutics' related companies.
Open | High | Low | Close | Volume | |
0.80 | 16.80 | 16.80 | 16.80 | 27,620 | |
05/12/2023 | 0.84 | 13.90 | 13.90 | 13.90 | 53,727 |
0.68 | 12.57 | 12.57 | 12.57 | 17,871 |
Backtest Acorda Therapeutics | | | Acorda Therapeutics History | | | Acorda Therapeutics Valuation | Previous | Next |
Acorda Therapeutics Trading Date Momentum on May 12, 2023
On May 15 2023 Acorda Therapeutics was traded for 12.57 at the closing time. The top price for the day was 12.57 and the lowest listed price was 12.57 . The trading volume for the day was 17.9 K. The trading history from May 15, 2023 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 9.57% . The overall trading delta against the current closing price is 94.46% . |
Acorda Therapeutics Fundamentals Correlations and Trends
By evaluating Acorda Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Acorda Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Acorda financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Acorda Therapeutics Stock history
Acorda Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Acorda is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Acorda Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Acorda Therapeutics stock prices may prove useful in developing a viable investing in Acorda Therapeutics
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. Acorda Therapeutics, Inc. was incorporated in 1995 and is headquartered in Ardsley, New York. Acorda Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 118 people.
Acorda Therapeutics Stock Technical Analysis
Acorda Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Acorda Therapeutics Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Acorda Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Acorda Therapeutics November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Acorda Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Acorda Therapeutics shares will generate the highest return on investment. By undertsting and applying Acorda Therapeutics stock market strength indicators, traders can identify Acorda Therapeutics entry and exit signals to maximize returns
Acorda Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Acorda Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Acorda Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Acorda to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0834 | |||
Jensen Alpha | 1.25 | |||
Total Risk Alpha | (0.82) | |||
Sortino Ratio | 0.1651 | |||
Treynor Ratio | (1.00) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Acorda Stock
If you are still planning to invest in Acorda Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acorda Therapeutics' history and understand the potential risks before investing.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |